West Pharmaceutical Services Operating Income 2010-2024 | WST

West Pharmaceutical Services annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • West Pharmaceutical Services operating income for the quarter ending September 30, 2024 was $0.161B, a 9.02% decline year-over-year.
  • West Pharmaceutical Services operating income for the twelve months ending September 30, 2024 was $0.571B, a 11.41% decline year-over-year.
  • West Pharmaceutical Services annual operating income for 2023 was $0.676B, a 7.9% decline from 2022.
  • West Pharmaceutical Services annual operating income for 2022 was $0.734B, a 2.43% decline from 2021.
  • West Pharmaceutical Services annual operating income for 2021 was $0.752B, a 84.89% increase from 2020.
West Pharmaceutical Services Annual Operating Income
(Millions of US $)
2023 $676
2022 $734
2021 $752
2020 $407
2019 $297
2018 $240
2017 $226
2016 $195
2015 $129
2014 $182
2013 $162
2012 $135
2011 $110
2010 $91
2009 $98
West Pharmaceutical Services Quarterly Operating Income
(Millions of US $)
2024-09-30 $161
2024-06-30 $126
2024-03-31 $123
2023-12-31 $161
2023-09-30 $177
2023-06-30 $183
2023-03-31 $155
2022-12-31 $130
2022-09-30 $186
2022-06-30 $228
2022-03-31 $190
2021-12-31 $184
2021-09-30 $181
2021-06-30 $211
2021-03-31 $176
2020-12-31 $116
2020-09-30 $99
2020-06-30 $104
2020-03-31 $88
2019-12-31 $78
2019-09-30 $67
2019-06-30 $81
2019-03-31 $71
2018-12-31 $66
2018-09-30 $61
2018-06-30 $60
2018-03-31 $53
2017-12-31 $60
2017-09-30 $63
2017-06-30 $42
2017-03-31 $61
2016-12-31 $53
2016-09-30 $51
2016-06-30 $61
2016-03-31 $30
2015-12-31 $45
2015-09-30 $-4
2015-06-30 $39
2015-03-31 $48
2014-12-31 $45
2014-09-30 $44
2014-06-30 $54
2014-03-31 $39
2013-12-31 $37
2013-09-30 $40
2013-06-30 $43
2013-03-31 $43
2012-12-31 $32
2012-09-30 $26
2012-06-30 $36
2012-03-31 $42
2011-12-31 $27
2011-09-30 $26
2011-06-30 $28
2011-03-31 $29
2010-12-31 $6
2010-09-30 $25
2010-06-30 $31
2010-03-31 $29
2009-12-31 $22
2009-09-30 $26
2009-06-30 $29
2009-03-31 $21
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $24.592B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $76.568B 20.89
Becton Dickinson (BDX) United States $71.603B 18.76
Cardinal Health (CAH) United States $30.919B 16.77
Straumann Holding AG (SAUHY) Switzerland $23.137B 0.00
Labcorp (LH) United States $20.594B 17.08
Cooper (COO) United States $19.559B 26.49
Align Technology (ALGN) United States $16.756B 32.06
Henry Schein (HSIC) United States $9.958B 18.97
Merit Medical Systems (MMSI) United States $6.322B 32.29
DENTSPLY SIRONA (XRAY) United States $3.902B 10.61
Patterson (PDCO) United States $2.733B 14.60
CONMED (CNMD) United States $2.174B 18.14
STAAR Surgical (STAA) United States $1.192B 43.98
Lifevantage (LFVN) United States $0.274B 36.50
Pro-Dex (PDEX) United States $0.141B 28.09